Overcoming multidrug resistance with nanomedicines

Area of Science:

• Oncology
• Nanotechnology
• Pharmacology

Background:

• Cancer is a leading global cause of death.
• Multidrug resistance (MDR) significantly hinders effective cancer chemotherapy.
• Developing targeted therapies is crucial for overcoming treatment resistance.

Purpose of the Study:

• To explore nanomedicine strategies for treating multidrug-resistant (MDR) tumors.
• To elucidate the mechanisms by which nanomedicines overcome MDR.
• To provide a mechanistic overview of targeting tumors with nanoparticles.

Main Methods:

• Discussion of the MDR phenomenon and key resistance proteins.
• Characterization of structural and functional aspects of MDR proteins.
• Description of nanoparticle-based tumor targeting strategies.

Main Results:

• Nanomedicines can be engineered to target MDR tumors.
• Strategies focus on modulating the drug influx:efflux ratio.
• Nanoparticles can bypass efflux pumps and increase intracellular drug concentrations.

Conclusions:

• Nanomedicines represent a viable approach to combat cancer MDR.
• Chemosensitizers and nanomedicine delivery vehicles enhance therapeutic outcomes.
• These strategies improve drug delivery to resistant cancer cells, boosting treatment response.